Q&A: Through robotics, Fred Parietti and team look to fix cell therapy’s future

There’s a bottleneck in manufacturing right now, and perhaps the category that is the best representative of the issue is cell and gene therapy. Several companies are trying different things to address the issue, but Multiply Labs has enlisted some CDMO powerhouses on its path toward the automation of the...

Click to view original post